These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36100912)

  • 1. Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya.
    Zhou Z; Gimnig JE; Sergent SB; Liu Y; Abong'o B; Otieno K; Chebore W; Shah MP; Williamson J; Ter Kuile FO; Hamel MJ; Kariuki S; Desai M; Samuels AM; Walker ED; Shi YP
    Malar J; 2022 Sep; 21(1):265. PubMed ID: 36100912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.
    Shah M; Omosun Y; Lal A; Odero C; Gatei W; Otieno K; Gimnig JE; ter Kuile F; Hawley WA; Nahlen B; Kariuki S; Walker E; Slutsker L; Hamel M; Shi YP
    Malar J; 2015 Feb; 14():75. PubMed ID: 25889220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
    Spalding MD; Eyase FL; Akala HM; Bedno SA; Prigge ST; Coldren RL; Moss WJ; Waters NC
    Malar J; 2010 Nov; 9():338. PubMed ID: 21106088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar.
    Wu Y; Soe MT; Aung PL; Zhao L; Zeng W; Menezes L; Yang Z; Kyaw MP; Cui L
    Malar J; 2020 Aug; 19(1):304. PubMed ID: 32854686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of Antimalarial Drugs on
    Hemming-Schroeder E; Umukoro E; Lo E; Fung B; Tomás-Domingo P; Zhou G; Zhong D; Dixit A; Atieli H; Githeko A; Vardo-Zalik A; Yan G
    Am J Trop Med Hyg; 2018 Mar; 98(3):692-699. PubMed ID: 29363453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia.
    Hassen J; Alemayehu GS; Dinka H; Golassa L
    Malar J; 2022 Oct; 21(1):286. PubMed ID: 36207750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
    Myers-Hansen JL; Abuaku B; Oyebola MK; Mensah BA; Ahorlu C; Wilson MD; Awandare G; Koram KA; Ngwa AA; Ghansah A
    PLoS One; 2020; 15(12):e0233478. PubMed ID: 33284800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
    Tadele G; Jawara A; Oboh M; Oriero E; Dugassa S; Amambua-Ngwa A; Golassa L
    Malar J; 2023 Jun; 22(1):171. PubMed ID: 37270589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
    Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan.
    Mohamed AO; Hussien M; Mohamed A; Suliman A; Elkando NS; Abdelbagi H; Malik EM; Abdelraheem MH; Hamid MMA
    Malar J; 2020 Feb; 19(1):78. PubMed ID: 32070355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
    Wurtz N; Fall B; Pascual A; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Bercion R; Briolant S; Wade B; Pradines B
    Malar J; 2012 Jun; 11():197. PubMed ID: 22694921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
    Dorkenoo AM; Warsame M; Ataba E; Hemou M; Yakpa K; Sossou E; Mitigmsagou M; Teou CD; Caspar E; Ma L; Djadou KE; Atcha-Oubou T; Rasmussen C; Menard D
    Malar J; 2024 Apr; 23(1):92. PubMed ID: 38570791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
    Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya.
    Chebore W; Zhou Z; Westercamp N; Otieno K; Shi YP; Sergent SB; Rondini KA; Svigel SS; Guyah B; Udhayakumar V; Halsey ES; Samuels AM; Kariuki S
    Malar J; 2020 Aug; 19(1):291. PubMed ID: 32795367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.
    Khan AQ; Pernaute-Lau L; Khattak AA; Luijcx S; Aydin-Schmidt B; Hussain M; Khan TA; Mufti FU; Morris U
    Malar J; 2020 Jun; 19(1):206. PubMed ID: 32513171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
    Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H.
    Pacheco MA; Schneider KA; Cheng Q; Munde EO; Ndege C; Onyango C; Raballah E; Anyona SB; Ouma C; Perkins DJ; Escalante AA
    Malar J; 2020 Oct; 19(1):378. PubMed ID: 33092587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.